Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Novacyt confirms end of Yourgene Taiwan disposal discussions

(Sharecast News) - Novacyt announced on Tuesday that it had received formal notification from INEX Innovate terminating discussions around the acquisition of Yourgene Health Taiwan. The AIM-traded firm noted that Yourgene Health initially announced the acquisition on 13 June 2023.

As a result of the termination, Yourgene's Taiwanese laboratory business would remain within the Novacyt group.

"The board does not consider the divestment material and will continue to evaluate a number of options in relation to the future of the Taiwanese laboratory business that offer the best value to all stakeholders," the Novacyt board said in its statement.

At 1158 GMT, shares in Novacyt were down 5.77% at 47.35p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

BNPP Exane downgrades Compass Group, shares slide
(Sharecast News) - Compass Group slumped on Wednesday after BNP Paribas Exane downgraded shares of the catering firm to 'underperform' from 'outperform'.
FDM points to uptick in demand after tough 2024
(Sharecast News) - FDM Group saw a big drop in revenues and profits in 2024, but shares rose strongly on Wednesday after the tech consultancy pointed to an "encouraging" start to 2025.
Alpha Group reports full-year growth in revenue, profits
(Sharecast News) - Alpha Group International reported a 23% increase in group revenue to £135.6m for the year ended 31 December on Wednesday, reflecting strong organic growth and the expanding contribution of its Cobase platform.
Ferrexpo accuses Ukraine of breaching treaty obligations
(Sharecast News) - Shares in Ferrexpo were sharply lower on Wednesday, after the iron ore producer accused Ukraine of breaching international investment agreements.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.